Indianapolis couple offers seniors a senior housing alternative
Unusual home on south side has a dozen bedrooms for folks who need to give up their own homes.
Health Care & Life Sciences
Articles
Hospital systems adopt Starbucks-style service
Indiana University Health is the latest system to drill employees ranging from clerks to physicians in how to treat patients.
Lechleiter: After the deluge, we’ll be fine
Eli Lilly and Co. CEO John Lechleiter visited Japan last week—three days before the massive earthquake—to deliver his tried-and-true message: Drug companies need to reinvent invention, governments needs to support innovation, and Lilly will be just fine after it has sustained the damage of the next three years.
Dow Agro thinks it has a winner
The Indianapolis-based company released more details this month about its Enlist Weed Control System, which would genetically modify corn, soybeans and cotton to be resistant to one of the most common weedkillers.
OneAmerica enjoys 24-percent surge in sales
The Indianapolis-based life insurer pulled in sales last year of $1.7 billion and boosted its overall assets 12 percent, to $24.4 billion.
Indiana Medicaid mental health list worries advocates
The state budget bill moving through the Indiana General Assembly would save about $7 million each year by creating a list of preferred mental health drugs and trying to win larger rebates from manufacturers.
Lilly agrees to buy European animal health company
Elanco, the animal health division of Eli Lilly and Co., has agreed to acquire Jannsen Animal Health, a subsidiary of New Jersey-based Johnson & Johnson, pending regulatory approval. Financial terms of the deal were not disclosed.
Purdue case highlights costs of defending intellectual property
A complicated legal case about trade secrets points up a down side to the success Indiana’s research universities have had turning their research into revenue: Large legal bills can eat much of the money.
Product delays thwart $40M Roche purchase
Delays getting new diabetes meters into the U.S. market appear to have tripped up Roche Diagnostics Corp. on its way to acquiring a key software vendor.
Peru immigrant built career on helping local Hispanics
Aida McCammon has spent 20 years helping Hispanics improve their lives and succeed in the United States.
HICKS: Unfortunately, veteran tuition benefits must be cut
It’s a wide entitlement program that will literally explode in the coming decades, since a third of all combat veterans will meet the disability requirements. It is not sustainable, and the Senate just tightened the requirements.
Irsay, Simon tie on magazine’s world’s-richest list
In a feat not possible for their teams, Indiana Pacers owner Herb Simon and Indianapolis Colts owner Jim Irsay tied for 879th place on Forbes magazine’s annual list of the richest people in the world. Bill Cook and Dean White also made the list.
Lilly confident of FDA approval for Amyvid, Lechleiter says
Eli Lilly and Co. CEO John Lechleiter said he’s confident of gaining U.S. regulatory approval for a drug to help identify plaque in the brain associated with Alzheimer’s disease.
Q&A: Tony Lennen
Tony Lennen became president of Community Hospital South in 2009, overseeing a 50-bed expansion that was completed last summer, giving the hospital 150 private rooms. The facility, located along the line between Marion and Johnson counties, competes against nearby facilities run by Franciscan St. Francis Health, Indiana University Health and Johnson Memorial Hospital.
Health insurance costs spike worldwide
Think galloping health insurance costs are a problem unique to American employers? Think again. Medical costs paid by employer-focused health insurers rose by an average of 10 percent last year—identical to the United States.
Lilly suffers another bruise from Novo
The failure of its drug Bydureon to match the performance of Novo’s Victoza trims but doesn’t kill sales prospects for the highly touted diabetes drug.
CNO Financial Chairman Hilliard stepping down
R. Glenn Hilliard, 68, who has held the chairman's title since September 2003, said he will not seek re-election.
Pharmacist accused of netting $3.5 million through fraud
A Terre Haute pharmacist faces a possible 10-year prison sentence if convicted of health care fraud and money laundering in a scheme that netted him more than $3.57 million.
OneAmerica promotes CFO Davison to executive vice president
With the company recently doubling in size, CEO Dayton Molendorp wanted another executive to guide the company’s further growth.
Lilly’s Bydureon falls short of competitor in study
Bydureon, the diabetes drug being developed by Amylin Pharmaceuticals Inc., Eli Lilly and Co. and Alkermes Inc., didn’t control the disease better than Novo Nordisk A/S’s Victoza in a study.